They will be using a VEGF Inhibitor [vascular endothelial growth factor] (Lucentis) in Refractory Macular Edema [aquous humor leakage] due to Eales’ Disease.
Eales Disease is a rare disorder of sight that appears as an inflammation and white haze around the outercoat of the veins in the retina. The disorder is most prevalent among young males and normally affects both eyes. Usually, vision is suddenly blurred because the clear jelly that fills the eyeball behind the lens of the eye seeps out (vitreous hemorrhaging).
Genentech (DNA) finished down in today's action 74 cents to 83.41 in active trading.
No comments:
Post a Comment